Subscribe to our Newsletters !!

    Aerogen

    Aerogen lowers the transmission risk of patient generated infectious aerosol

    Aerogen lowers the transmission risk of patient generated infectious aerosol as it sits above a closed circuit potentially reducing the risk of Healthcare Professional contamination from the circuit or patient1. Aerogen is the only closed-system high efficiency nebulizer that can be utilized for drug delivery with ventilators being used to treat COVID-19 patients. Aerogen Vibrating

    Aerogen – bringing a lower risk of transmission of patient generated infectious aerosol for healthcare professionals in acute care settings compared to traditional nebulisers

    India has 18% of the global population and an increasing burden of chronic respiratory diseases1. The technique of nebulisation is commonly utilised in the treatment of such diseases including asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD)2. Recent improvements in nebuliser technologies have led to the development of vibrating mesh nebulisers (VMNs) that produce

    Aerogen: An appropriate aerosol drug delivery system for the effective treatment of respiratory illness

    No matter what the respiratory illness, for mechanically ventilated or spontaneous breathing patients, Aerogen has the appropriate aerosol drug delivery system for the effective treatment of your patients. The illness includes: 1.COPD 2.Asthma 3.Cystic Fibrosis COPD Chronic Obstructive Pulmonary Disease (COPD) is among the very serious lung diseases prevalent today affecting 65 million people globally.

    Role of Aerogen Nebulization in High Flow Oxygen Therapy

    High flow oxygen therapy is a form of respiratory support used in the hospital where oxygen, often in conjunction with compressed air and humidification, is delivered to a patient at rates of flow higher than that delivered traditionally in oxygen therapy. High flow oxygen therapy is intended to Eliminate most of the anatomic dead space